18268209

Source:http://linkedlifedata.com/resource/pubmed/id/18268209

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0040864, umls-concept:C0078058, umls-concept:C0086418, umls-concept:C0534628, umls-concept:C0600518, umls-concept:C1171892, umls-concept:C1280500
pubmed:issue	2
pubmed:dateCreated	2008-2-12
pubmed:abstractText	To evaluate the early effects of triamcinolone acetonide as monotherapy or as an adjuvant to ocular verteporfin photodynamic therapy (PDT) on angiogenesis in human choroidal neovascularization (CNV) secondary to age-related macular degeneration.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7706534
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34, http://linkedlifedata.com/resource/pubmed/chemical/Endostatins, http://linkedlifedata.com/resource/pubmed/chemical/Keratin-18, http://linkedlifedata.com/resource/pubmed/chemical/Photosensitizing Agents, http://linkedlifedata.com/resource/pubmed/chemical/Porphyrins, http://linkedlifedata.com/resource/pubmed/chemical/Triamcinolone Acetonide, http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/verteporfin
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0003-9950
pubmed:author	pubmed-author:Bartz-SchmidtKarl UKU, pubmed-author:EckardtClausC, pubmed-author:GrisantiSalvatoreS, pubmed-author:KaiserlingEdwinE, pubmed-author:MohrAndreasA, pubmed-author:PertileGraziaG, pubmed-author:ShinodaKeiK, pubmed-author:SzurmanPeterP, pubmed-author:TatarOlcayO, pubmed-author:YoeruekEfdalE
pubmed:issnType	Print
pubmed:volume	126
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	193-9
pubmed:meshHeading	pubmed-meshheading:18268209-Aged, pubmed-meshheading:18268209-Aged, 80 and over, pubmed-meshheading:18268209-Anti-Inflammatory Agents, pubmed-meshheading:18268209-Antigens, CD34, pubmed-meshheading:18268209-Choroidal Neovascularization, pubmed-meshheading:18268209-Drug Therapy, Combination, pubmed-meshheading:18268209-Endostatins, pubmed-meshheading:18268209-Female, pubmed-meshheading:18268209-Humans, pubmed-meshheading:18268209-Immunoenzyme Techniques, pubmed-meshheading:18268209-Keratin-18, pubmed-meshheading:18268209-Macular Degeneration, pubmed-meshheading:18268209-Male, pubmed-meshheading:18268209-Middle Aged, pubmed-meshheading:18268209-Photochemotherapy, pubmed-meshheading:18268209-Photosensitizing Agents, pubmed-meshheading:18268209-Porphyrins, pubmed-meshheading:18268209-Retrospective Studies, pubmed-meshheading:18268209-Triamcinolone Acetonide, pubmed-meshheading:18268209-Vascular Endothelial Growth Factor A
pubmed:year	2008
pubmed:articleTitle	Early effects of triamcinolone on vascular endothelial growth factor and endostatin in human choroidal neovascularization.
pubmed:affiliation	Centre for Ophthalmology, University Eye Hospital, Eberhard-Karls University, Schleichstrasse 12-15, 72076 Tuebingen, Germany.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't